Clinical Trials Browser

Phase EARLY_PHASE1 × Estrogen Receptor-positive Breast Cancer × Letrozole × Clear all

NCT03962647 2026-04-30

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Phase EARLY_PHASE1 Completed

Estrogen Receptor-positive Breast Cancer